Condition: Neovascular Age-Related Macular Degeneration (nAMD) · Wet AMD · Sponsor: Innostellar Biotherapeutics Co.,Ltd
This is a Phase III, randomized, open-label, active-controlled study to evaluate the efficacy and safety of subretinal injection of LX102 in participants with neovascular age-related macular degeneration. The study will evaluate a single subretinal injection of LX102 compared to an active comparator. The primary endpoint of this study is the mean change from D0 in BCVA based on an average at weeks 40 and 48.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of University of Science and Technology of China | Hefei, Anhui, China | Not Yet Recruiting |
| Beijing Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Peking Union Medical College Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| The Second Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| The First Affiliated Hospital of Jinan University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| Joint Shantou International Eye Center, Shantou University and the Chinese University of Hong Kong | Shantou, Guangdong, China | Not Yet Recruiting |
| Zhongshan Ophthalmic Center, Sun Yat-sen University | Zhongshan, Guangdong, China | Not Yet Recruiting |
| The Second Affiliated Hospital of Harbin Medical University | Harbin, Heilongjiang, China | Not Yet Recruiting |
| Central Theater Command General Hospital of PLA | Wuhan, Hubei, China | Not Yet Recruiting |
| The Second Xiangya Hospital, Central South University | Changsha, Hunan, China | Not Yet Recruiting |
| Aier Eye Hospital Group Co., LTD. Changsha Aier Eye Hospital | Changsha, Hunan, China | Not Yet Recruiting |
| The Affiliated Eye Hospital of Nanjing Medical University | Nanjing, Jiangsu, China | Not Yet Recruiting |
+ 19 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07317934